1. Home
  2. List
Reference Patent

Reference - List

  • 79 Hits
  • Search Condition : Filter (Species = Human and Animal Cells AND Author's Country of Origin = France)
Species Resource Title
Human and Animal Cells 409B2(HPS0076) BiœmuS: A new tool for neurological disorders studies through real-time emulation and hybridization using biomimetic Spiking Neural Network.
Human and Animal Cells ATDC5(RCB0565) TMEM165 a new player in proteoglycan synthesis: loss of TMEM165 impairs elongation of chondroitin- and heparan-sulfate glycosaminoglycan chains of proteoglycans and triggers early chondrocyte differentiation and hypertrophy.
Human and Animal Cells ATDC5(RCB0565) Differential Effects of D-Galactose Supplementation on Golgi Glycosylation Defects in TMEM165 Deficiency.
Human and Animal Cells HCE-T(RCB2280) Photosensitizer-Amplified Antimicrobial Materials for Broad-spectrum Ablation of Resistant Pathogens in Ocular Infections.
Human and Animal Cells TUHR14TKB(RCB138) TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization.
Human and Animal Cells HCT116 Tet-OsTIR1(RCB4663) Non-canonical functions of UHRF1 maintain DNA methylation homeostasis in cancer cells.
Human and Animal Cells HuCCT1(RCB1960) , HuH-28(RCB1943) TGFβ-induced circLTBP2 predicts a poor prognosis in intrahepatic cholangiocarcinoma and mediates gemcitabine resistance by sponging miR-338-3p.
Human and Animal Cells HUDEP-2(RCB4557) Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype.
Human and Animal Cells HUDEP-2(RCB4557) Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies.
Human and Animal Cells HUDEP-2(RCB4557) Combination of lentiviral and genome editing technologies for the treatment of sickle cell disease.
Human and Animal Cells HUDEP-2(RCB4557) Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins.
Human and Animal Cells HUDEP-2(RCB4557) Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells.
Human and Animal Cells JHOC-5(RCB1520) Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma.
Human and Animal Cells NB1RGB(RCB0222) Simulation of DNA damage using Geant4‐DNA: an overview of the “molecularDNA” example application
Human and Animal Cells HUDEP-2(RCB4557) Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression.
Human and Animal Cells RAW 264(RCB0535) Bis(monoacylglycero)phosphate accumulation in macrophages induces intracellular cholesterol redistribution, attenuates liver-X receptor/ATP-Binding cassette transporter A1/ATP-binding cassette transporter G1 pathway, and impairs cholesterol efflux.
Human and Animal Cells PC-3(RCB2145) Fluorizoline Blocks the Interaction between Prohibitin-2 and γ-Glutamylcyclotransferase and Induces p21Waf1/Cip1 Expression in MCF7 Breast Cancer Cells.
Human and Animal Cells HCE-T(RCB1384) In Vitro Corneal and Conjunctival Wound-Healing Assays as a Tool for Antiglaucoma Prostaglandin Formulation Characterization.
Human and Animal Cells Hepa-E1(RCB1155) Cellular and molecular mechanisms of NiONPs toxicity on eel hepatocytes HEPA-E1: An illustration of the impact of Ni release from mining activity in New Caledonia.
Human and Animal Cells KGN(RCB1154) Estradiol promotes cell survival and induces Greb1 expression in granulosa cell tumors of the ovary through an ERα-dependent mechanism.